The recall affects 15mg/ml (75 mg/5ml) nizatidine oral solutions packaged in 480 ml bottles the ndc number for the recalled medication is 60846-301-15 with lot numbers that include 06598004a. What acid reflux medication was recalled. Acid reflux drug recalled due to possible carcinogen mylan pharmaceuticals has issued a voluntary nationwide recall of three lots of nizatidine capsules due to a substance that could cause cancer.
what acid reflux medication was recalled
These medications work to prevent heartburn and provide relief tied to acid ingestion by reducing the amount of acid the stomach makes the prescription version is used to treat and prevent ulcers of the stomach; it also treats gastroesophageal reflux disease (gerd) this recall was recently expanded to include the following products:. (rxwiki news) the us food and drug administration (fda) has released an update about the recall of a common heartburn medication. the fda has discovered that some medications used for acid reflux contain low levels of a possible cancer-causing impurity. these medications are found under the names ranitidine (active ingredient) and zantac (brand). these drugs are available over the counter and. The heartburn medications in the recall all contain the ingredient ranitidine. it's an acid reducer to lessen the frequency and severity of heartburn. it's also used to treat stomach ulcers..
